Literature DB >> 21468762

What is the relationship between ¹⁸F-FDG aortic aneurysm uptake on PET/CT and future growth rate?

Carl W Kotze1, Ashley M Groves, Leon J Menezes, Richard Harvey, Raymondo Endozo, Irfan A Kayani, Peter J Ell, Syed W Yusuf.   

Abstract

PURPOSE: In this study we investigate the relationship between (18)F-fluorodeoxyglucose (FDG) metabolism and future aneurysm expansion measured by serial duplex ultrasound. Current screening programmes are increasing the identification of patients with abdominal aortic aneurysm (AAA). The management of these patients remains challenging and methods of risk stratification are sought.
METHODS: Thirty-four consecutive patients [31 men, 3 women, median age 75 years, interquartile range (IQR) 71-78] with aortic aneurysms under routine surveillance with serial ultrasound were prospectively recruited for (18)F-FDG positron emission tomography (PET)/CT. A whole vessel type analysis was performed measuring the highest aortic wall (18)F-FDG uptake (standardized uptake value or SUV(max)), and target to background ratio (TBR) for each axial image and median SUV(max) and TBR value were calculated. Institutional Review Board permission and informed patient consent were obtained.
RESULTS: Nine patients failed to undergo 12-month follow-up study (deceased n = 2, withdrew n = 1, failed to attend ultrasound scan n = 5, emergency aneurysm repair n = 1) leaving 25 patients for analysis. The median whole vessel SUV(max) was 1.70 (IQR 1.45-2.08). The median whole vessel TBR was 1.15 (IQR 1.00-1.40). The median aneurysm expansion at 12 months was 2.0 mm (IQR 0.5-5.0). The correlation (r) between (18)F-FDG SUV(max) and ultrasound expansion at 1 year was -0.501 (p = 0.011).
CONCLUSION: The preliminary findings from this observational longitudinal pilot study suggest that there is an inverse trend between (18)F-FDG uptake on PET and future AAA expansion. Aortic aneurysms with lower metabolic activity may therefore be more likely to expand.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21468762     DOI: 10.1007/s00259-011-1799-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  43 in total

Review 1.  Aortic aneurysms: an immune disease with a strong genetic component.

Authors:  Helena Kuivaniemi; Chris D Platsoucas; M David Tilson
Journal:  Circulation       Date:  2008-01-15       Impact factor: 29.690

Review 2.  Inflammation and cytokine signaling in aneurysms.

Authors:  W D McMillan; W H Pearce
Journal:  Ann Vasc Surg       Date:  1997-09       Impact factor: 1.466

3.  What is the natural history of 18F-FDG uptake in arterial atheroma on PET/CT? Implications for imaging the vulnerable plaque.

Authors:  Leon J Menezes; Irfan Kayani; Simona Ben-Haim; Brian Hutton; Peter J Ell; Ashley M Groves
Journal:  Atherosclerosis       Date:  2010-01-22       Impact factor: 5.162

4.  (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials.

Authors:  James H F Rudd; Kelly S Myers; Sameer Bansilal; Josef Machac; Ash Rafique; Michael Farkouh; Valentin Fuster; Zahi A Fayad
Journal:  J Am Coll Cardiol       Date:  2007-08-13       Impact factor: 24.094

5.  Anatomic characteristics of ruptured abdominal aortic aneurysm on conventional CT scans: Implications for rupture risk.

Authors:  Mark F Fillinger; Jessica Racusin; Robert K Baker; Jack L Cronenwett; Arno Teutelink; Marc L Schermerhorn; Robert M Zwolak; Richard J Powell; Daniel B Walsh; Eva M Rzucidlo
Journal:  J Vasc Surg       Date:  2004-06       Impact factor: 4.268

6.  High levels of 18F-FDG uptake in aortic aneurysm wall are associated with high wall stress.

Authors:  X Y Xu; A Borghi; A Nchimi; J Leung; P Gomez; Z Cheng; J O Defraigne; N Sakalihasan
Journal:  Eur J Vasc Endovasc Surg       Date:  2009-11-18       Impact factor: 7.069

7.  Increased metabolic activity in abdominal aortic aneurysm detected by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT).

Authors:  C W Kotze; L J Menezes; R Endozo; A M Groves; P J Ell; S W Yusuf
Journal:  Eur J Vasc Endovasc Surg       Date:  2009-02-12       Impact factor: 7.069

8.  The prevalence of inflammation in carotid atherosclerosis: analysis with fluorodeoxyglucose-positron emission tomography.

Authors:  Nobuhiro Tahara; Hisashi Kai; Hiroyuki Nakaura; Minori Mizoguchi; Masatoshi Ishibashi; Hayato Kaida; Kenkichi Baba; Naofumi Hayabuchi; Tsutomu Imaizumi
Journal:  Eur Heart J       Date:  2007-08-05       Impact factor: 29.983

9.  Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study.

Authors:  James H F Rudd; Kelly S Myers; Sameer Bansilal; Josef Machac; Mark Woodward; Valentin Fuster; Michael E Farkouh; Zahi A Fayad
Journal:  Circ Cardiovasc Imaging       Date:  2009-01-26       Impact factor: 7.792

10.  Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.

Authors:  J H F Rudd; E A Warburton; T D Fryer; H A Jones; J C Clark; N Antoun; P Johnström; A P Davenport; P J Kirkpatrick; B N Arch; J D Pickard; P L Weissberg
Journal:  Circulation       Date:  2002-06-11       Impact factor: 29.690

View more
  27 in total

1.  Integrin-targeted molecular imaging of experimental abdominal aortic aneurysms by (18)F-labeled Arg-Gly-Asp positron-emission tomography.

Authors:  Toshiro Kitagawa; Hisanori Kosuge; Edwin Chang; Michelle L James; Tomoaki Yamamoto; Bin Shen; Frederick T Chin; Sanjiv S Gambhir; Ronald L Dalman; Michael V McConnell
Journal:  Circ Cardiovasc Imaging       Date:  2013-08-30       Impact factor: 7.792

Review 2.  Molecular imaging of aortic aneurysms.

Authors:  Denis B Buxton
Journal:  Circ Cardiovasc Imaging       Date:  2012-05-01       Impact factor: 7.792

Review 3.  Molecular imaging in atherosclerosis: FDG PET.

Authors:  David Rosenbaum; Antoine Millon; Zahi A Fayad
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

Review 4.  Multi-modality molecular imaging of aortic aneurysms.

Authors:  Brian J Malm; Mehran M Sadeghi
Journal:  J Nucl Cardiol       Date:  2017-04-26       Impact factor: 5.952

Review 5.  Emergence of molecular imaging of aortic aneurysm: implications for risk stratification and management.

Authors:  Reza Golestani; Mehran M Sadeghi
Journal:  J Nucl Cardiol       Date:  2014-01-01       Impact factor: 5.952

6.  Imaging vessel wall biology to predict outcome in abdominal aortic aneurysm.

Authors:  Reza Golestani; Mahmoud Razavian; Lei Nie; Jiasheng Zhang; Jae-Joon Jung; Yunpeng Ye; Michelle de Roo; Koen Hilgerink; Chi Liu; Simon P Robinson; Mehran M Sadeghi
Journal:  Circ Cardiovasc Imaging       Date:  2014-12-30       Impact factor: 7.792

7.  Imaging Biological Pathways in Abdominal Aortic Aneurysms Using Positron Emission Tomography.

Authors:  Michael Bell; Richa Gandhi; Heba Shawer; Charalampos Tsoumpas; Marc A Bailey
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-03-25       Impact factor: 8.311

8.  Increased 18F-FDG uptake is predictive of rupture in a novel rat abdominal aortic aneurysm rupture model.

Authors:  Sean J English; Morand R Piert; Jose A Diaz; David Gordon; Abhijit Ghosh; Louis G DʼAlecy; Steven E Whitesall; Ashish K Sharma; Elise P DeRoo; Tessa Watt; Gang Su; Peter K Henke; Jonathan L Eliason; Gorav Ailawadi; Gilbert R Upchurch
Journal:  Ann Surg       Date:  2015-02       Impact factor: 12.969

Review 9.  Novel Molecular Imaging Approaches to Abdominal Aortic Aneurysm Risk Stratification.

Authors:  Jakub Toczek; Judith L Meadows; Mehran M Sadeghi
Journal:  Circ Cardiovasc Imaging       Date:  2016-01       Impact factor: 7.792

10.  Cell proliferation detected using [18F]FLT PET/CT as an early marker of abdominal aortic aneurysm.

Authors:  Richa Gandhi; Christopher Cawthorne; Lucinda J L Craggs; John D Wright; Juozas Domarkas; Ping He; Joanna Koch-Paszkowski; Michael Shires; Andrew F Scarsbrook; Stephen J Archibald; Charalampos Tsoumpas; Marc A Bailey
Journal:  J Nucl Cardiol       Date:  2019-11-18       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.